Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 6,841	$ 12,694
Short-term investments	252	498
Accounts receivable (net of allowance for doubtful accounts of $88 in 2023 and $72 in 2022)	10,349	9,450
Inventories (excludes inventories of $3,348 in 2023 and $2,938 in 2022 classified in Other assets - see Note 8)	6,358	5,911
Other current assets	8,368	7,169
Total current assets	32,168	35,722
Investments	252	1,015
Property, Plant and Equipment (at cost)
Land	326	295
Buildings	14,966	13,166
Machinery, equipment and office furnishings	17,763	16,760
Construction in progress	8,262	9,186
Property, plant and equipment (at cost)	41,317	39,407
Less: accumulated depreciation	18,266	17,985
Property, plant and equipment, net	23,051	21,422
Goodwill	21,197	21,204
Other Intangibles, Net	18,011	20,269
Other Assets	11,996	9,528
Total Assets	106,675	109,160
Current Liabilities
Loans payable and current portion of long-term debt	1,372	1,946
Trade accounts payable	3,922	4,264
Accrued and other current liabilities	15,766	14,159
Income taxes payable	2,649	1,986
Dividends payable	1,985	1,884
Total current liabilities	25,694	24,239
Long-Term Debt	33,683	28,745
Deferred Income Taxes	871	1,795
Other Noncurrent Liabilities	8,792	8,323
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2023 and 2022	1,788	1,788
Other paid-in capital	44,509	44,379
Retained earnings	53,895	61,081
Accumulated other comprehensive loss	(5,161)	(4,768)
Stockholders' equity before deduction for treasury stock	95,031	102,480
Less treasury stock, at cost: 1,045,470,249 shares in 2023 and 1,039,269,638 shares in 2022	57,450	56,489
Total Merck & Co., Inc. stockholders’ equity	37,581	45,991
Noncontrolling Interests	54	67
Total equity	37,635	46,058
Total Liabilities and Equity	$ 106,675	$ 109,160